BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6100055)

  • 1. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
    Horiuchi K
    Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
    Oka T; Iseki K; Oka R; Sakuma S; Yoshioka H; Takahashi M
    Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection.
    Asano Y; Yazaki T; Miyata T; Nakayama H; Hirose S
    Biken J; 1975 Mar; 18(1):35-40. PubMed ID: 167708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated varicella vaccine in children with leukemia in remission.
    Gershon AA; Steinberg S; Galasso G; Borkowsky W; Larussa P; Ferrara A; Gelb L
    Biken J; 1984 Sep; 27(2-3):77-81. PubMed ID: 6100063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of acute leukemic children with a live varicella vaccine (Oka strain).
    Kamiya H; Kato T; Isaji M; Torigoe S; Oitani K; Ito M; Ihara T; Sakurai M; Takahashi M
    Biken J; 1984 Sep; 27(2-3):99-102. PubMed ID: 6100066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical observations on varicella-zoster vaccinees treated with immunosuppressants for a malignancy.
    Nunoue T
    Biken J; 1984 Sep; 27(2-3):115-8. PubMed ID: 6100047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children.
    Asano Y; Takahashi M
    Pediatrics; 1977 Dec; 60(6):810-4. PubMed ID: 202916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect and follow-up study on varicella vaccine.
    Katsushima N; Yazaki N; Sakamoto M
    Biken J; 1984 Sep; 27(2-3):51-8. PubMed ID: 6100058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immune response to varicella-zoster virus in children inoculated with live attenuated varicella vaccine.
    Kumagai T; Chiba Y; Fujiwara M; Hanazono H; Nakamura S; Chiba S; Nakao T; Takahashi M
    Biken J; 1980 Sep; 23(3):135-41. PubMed ID: 6257227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live varicella vaccine in healthy individuals.
    Just M; Berger R; Luescher D
    Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.